Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Bailey and Dynarski cited in piece on why quality education should be a "civil and moral right"

Kalousova and Burgard find credit card debt increases likelihood of foregoing medical care

Bachman says findings on teens' greater materialism, slipping work ethic should be interpreted with caution

Highlights

Arline Geronimus wins Excellence in Research Award from School of Public Health

Yu Xie to give DBASSE's David Lecture April 30, 2013 on "Is American Science in Decline?"

U-M grad programs do well in latest USN&WR "Best" rankings

Sheldon Danziger named president of Russell Sage Foundation

Next Brown Bag



Back in September

Twitter Follow us 
on Twitter 

COMORBID ANXIETY AS A SUICIDE RISK FACTOR AMONG DEPRESSED VETERANS

Archived Abstract of Former PSC Researcher

Pfeiffer, P.N., D. Ganoczy, M. Ilgen, Kara Zivin, and M. Valenstein. 2009. "COMORBID ANXIETY AS A SUICIDE RISK FACTOR AMONG DEPRESSED VETERANS." Depression and Anxiety, 26(8): 752-757.

Background: Depressive disorders greatly increase suicide risk; however, little is known about the contribution of comorbid anxiety disorders or anxiety symptoms to the risk of suicide death among depressed patients. We examined whether depressed veterans with comorbid anxiety had higher risks of suicide death. Methods: Using VA administrative databases we identified 887,859 patients with depression. We then used univariate and multivariate logistic regression, controlling for demographics and substance use disorders, to determine the odds ratios of completed suicide associated with individual comorbid anxiety disorders, the presence of any comorbid anxiety disorder, the prescription of an antianxiety medication, or the prescription of a high dose of an antianxiety medication. Results: In multivariate analyses, the odds of completed suicide were significantly increased for patients with panic disorder (OR 1.26, 95% CI. 1.04-1.53), generalized anxiety disorder (OR 1.27, 95% CI: 1.09-1.47), and anxiety disorder, not otherwise specified (OR 1.25, 95% CI. 1.12-1.38). The odds of completed suicide were also greater among patients who received any antianxiety medication (OR 1.71, 95% CL 1.55-1.88), and were further increased among those who received high dose treatment (OR 2.26, 95% CI. 1.98-2.57). Odds of completed suicide were decreased among patients with comorbid posttraumatic stress disorder (OR 0.87, 95% CI. 0.77-0.97), and there was no statistically significant relationship between social phobia, obsessive-compulsive disorder, and all other anxiety disorders and suicide. Conclusions: These findings emphasize the importance of comorbid anxiety disorders and symptoms in increasing suicide risk among depressed patients and may inform suicide prevention efforts among these patients. Depression and Anxiety 26.752-757, 2009. (C) 2009 Wiley-Liss, Inc.

DOI:10.1002/da.20583 (Full Text)

PMCID: PMC2935592. (Pub Med Central)

Country of focus: United States.

Browse | Search : All Pubs | Next